BackgroundAnimal models of Alzheimer’s disease (AD) are essential tools for investigating disease pathophysiology and conducting preclinical drug testing.
Anett Futácsi +13 more
doaj +1 more source
Vigabatrin and Tiagabine Might have Antipanic Properties [PDF]
Rupprecht, Rainer, Zwanzger, P.
core +1 more source
Correction: Evaluating the therapeutic efficacy of gastramide theranostics targeting cholecystokinin-2 receptors in a preclinical setting. [PDF]
Rahimi MN +6 more
europepmc +1 more source
Glucose Intake during the Neonatal Period Modulates the Central Melanocortin System with Breed-Specific Differences. [PDF]
Kimura K +6 more
europepmc +1 more source
Cholecystokinin A Receptor Knockdown Diminishes Colon Cancer Cell Invasive Potential via Modulation of Integrin/FAK, EMT, and uPA/uPAR/MMP2 Axis. [PDF]
Lin CS, Hsu TW, Lee HL, Kao SH.
europepmc +1 more source
Comparison of receptor expression and cholecystokinin signaling between left and right nodose ganglia. [PDF]
Ritchey CR, McCune KX, Peters JH.
europepmc +1 more source
Decoding the Heart Failure Peptidome. [PDF]
Madsen CT +10 more
europepmc +1 more source
Cholecystokinin inhibits myotube fusion and may contribute to sarcopenia: Evidence from clinical and C2C12 myoblast studies. [PDF]
Liao PH +7 more
europepmc +1 more source
Spatiotemporal characterization of ghrelin and cholecystokinin levels in the gastrointestinal tract of juvenile S<i>parus aurata</i>: effects of feeding status and diet composition. [PDF]
Caderno A +7 more
europepmc +1 more source

